Semaglutide is a synthetic GLP-1 receptor agonist research peptide modeled after naturally occurring incretin hormones found in the body.
Laboratory research frequently examines its interaction with GLP-1 receptor pathways in studies involving appetite-related signaling, satiety-focused research models, metabolic activity, nutrient utilization, and body composition-focused laboratory applications.
Researchers continue to investigate its relationship to incretin-associated signaling pathways and metabolic research environments.
Semaglutide is supplied as a white lyophilized powder and is soluble in water.
This product is strictly for research purposes only.
